Related references
Note: Only part of the references are listed.Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report
Dysoley Lek et al.
MALARIA JOURNAL (2020)
A Temporizing Solution to Artemisinin Resistance
Jigang Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Novel As Broaches to Control Malaria in Forested Areas of Southeast Asia
Lorenz von Seidlein et al.
TRENDS IN PARASITOLOGY (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Malaria resurgence after significant reduction by mass drug administration on Ngodhe Island, Kenya
Wataru Kagaya et al.
SCIENTIFIC REPORTS (2019)
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross et al.
NATURE COMMUNICATIONS (2018)
Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis
Julie Gutman et al.
LANCET INFECTIOUS DISEASES (2017)
Emergence of Plasmodium falciparum triple mutant in Cambodia
Gabriele Rossi et al.
LANCET INFECTIOUS DISEASES (2017)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
Hannah C. Slater et al.
MALARIA JOURNAL (2016)
Quality of Antimalarials at the Epicenter of Antimalarial Drug Resistance: Results from an Overt and Mystery Client Survey in Cambodia
Shunmay Yeung et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
How could preventive therapy affect the prevalence of drug resistance? Causes and consequences
Amber Kunkel et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
Optimum population-level use of artemisinin combination therapies: a modelling study
Tran Dang Nguyen et al.
LANCET GLOBAL HEALTH (2015)
Artemisinin resistance - modelling the potential human and economic costs
Yoel Lubell et al.
MALARIA JOURNAL (2014)
Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance
Richard J. Maude et al.
PLOS ONE (2012)
Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling
Adrian E. Raftery et al.
BIOMETRICS (2010)
Plasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite Fitness
Piyanuch Preechapornkul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
Richard J. Maude et al.
MALARIA JOURNAL (2009)
Prospects for Malaria Eradication in Sub-Saharan Africa
Ricardo Aguas et al.
PLOS ONE (2008)
Benefits of using multiple first-line therapies against malaria
Maciej F. Boni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Modeling epidemics of multidrug-resistant M-tuberculosis of heterogeneous fitness
T Cohen et al.
NATURE MEDICINE (2004)
Share Paper
